Related Experiment Video
Updated: May 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Methylation of RASSF1A gene promoter is regulated by p53 and DAXX
Hailong Zhang1, Jing He, Jiansha Li
1Division of Hematology/Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Abstract:
Inactivation of the tumor suppressor Ras-association domain family 1 isoform A (RASSF1A) due to epigenetic silencing occurs in a variety of human cancers, and still largely unknown are the regulators and mechanisms underlying RASSF1A gene promoter methylation. Herein, we report that this methylation is regulated by p53 and death-associated protein 6 (DAXX) in acute lymphoblastic leukemia (ALL). We found that p53 bound to the RASSF1A promoter, recruiting DAXX as well as DNA methyltransferase 1 (DNMT1) for DNA methylation, which subsequently resulted in inactivation of RASSF1A in wild-type p53 ALL cells. Although the presence of p53 was required for the recruitment of DAXX and DNMT1 to the RASSF1A promoter, fluctuation in p53 protein levels did not affect the rates of RASSF1A methylation. Conversely, methylation of RASSF1A promoter was critically controlled by DAXX, as the enforced overexpression of DAXX led to enhanced RASSF1A promoter methylation, whereas inhibition of DAXX reduced RASSF1A methylation. Interestingly, we found that the p53/DAXX-mediated RASSF1A methylation regulated murine double minute 2 (MDM2) protein stability in ALL. Our results reveal a novel function for p53 in the methylation of RASSF1A promoter by its interaction with DAXX. Discovery of this mechanism provides new insight into the interactions among the tumor-related factors p53, RASSF1A, DAXX, and MDM2 in cancer pathogenesis.
Insights
p53 and DAXX regulate RASSF1A gene promoter methylation in acute lymphoblastic leukemia (ALL). This epigenetic silencing of the RASSF1A tumor suppressor impacts cancer pathogenesis by influencing MDM2 protein stability.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic silencing of the RASSF1A tumor suppressor gene is implicated in various human cancers.
- The precise mechanisms and regulators of RASSF1A promoter methylation remain largely undefined.
Purpose of the Study:
- To elucidate the roles of p53 and DAXX in regulating RASSF1A promoter methylation in acute lymphoblastic leukemia (ALL).
- To investigate the functional consequences of this methylation on cancer-related proteins like MDM2.
Main Methods:
- Chromatin immunoprecipitation assays to assess protein binding to the RASSF1A promoter.
- DNA methylation analysis.
- Gene and protein expression studies.
- Overexpression and inhibition experiments for DAXX and p53.
Main Results:
- p53 binds to the RASSF1A promoter, recruiting DAXX and DNMT1, leading to RASSF1A methylation and inactivation in wild-type p53 ALL cells.
- DAXX is a critical regulator of RASSF1A methylation, with its levels directly correlating with methylation rates.
- p53/DAXX-mediated RASSF1A methylation influences the stability of MDM2 protein in ALL.
Conclusions:
- p53 interacts with DAXX to mediate RASSF1A promoter methylation, revealing a novel regulatory pathway.
- This mechanism provides new insights into the interplay between p53, RASSF1A, DAXX, and MDM2 in cancer development.
- Understanding this epigenetic regulation in ALL offers potential therapeutic targets.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Master Transcription Regulators
Negative Regulator Molecules
The Ras Gene
Ras is a superfamily...

